<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Technology Feed]]></title><description><![CDATA[Latest Technology articles]]></description><link>https://github.com/iMahir/newrss</link><generator>RSS for Node</generator><lastBuildDate>Thu, 04 Jul 2024 11:14:13 GMT</lastBuildDate><atom:link href="https://github.com/iMahir/newrss/data/rss/technology.xml" rel="self" type="application/rss+xml"/><pubDate>Thu, 04 Jul 2024 11:14:13 GMT</pubDate><language><![CDATA[en]]></language><ttl>600000</ttl><item><title><![CDATA[J2 Ventures, focused on military healthcare, grabs $150M for its second fund]]></title><description><![CDATA[<p>J2 Ventures, a firm led mostly by the U.S. military veterans, announced on Thursday that it has raised a $150 million second fund. The Boston-based firm invests in startups whose products are purchased by civilians and the U.S. Department of Defense.   While many emerging VCs are struggling to raise second funds, J2’s latest vehicle is [&#8230;]</p>
<p>© 2024 TechCrunch. All rights reserved. For personal use only.</p>
]]></description><link>https://techcrunch.com/2024/07/04/j2-ventures-focused-on-military-healthcare-grabs-150m-for-its-second-fund/</link><guid isPermaLink="true">https://techcrunch.com/2024/07/04/j2-ventures-focused-on-military-healthcare-grabs-150m-for-its-second-fund/</guid><pubDate>Thu, 04 Jul 2024 11:00:00 GMT</pubDate></item><item><title><![CDATA[Wegovy, Ozempic linked with sight-threatening eye disorder in study - Reuters.com]]></title><description><![CDATA[<ol><li><a href="https://news.google.com/rss/articles/CBMihwFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy93ZWdvdnktb3plbXBpYy1saW5rZWQtd2l0aC1zaWdodC10aHJlYXRlbmluZy1leWUtZGlzb3JkZXItc3R1ZHktMjAyNC0wNy0wMy_SAQA?oc=5" target="_blank">Wegovy, Ozempic linked with sight-threatening eye disorder in study</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters.com</font></li><li><a href="https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjQvMDcvMDQvbm92by1ub3JkaXNrLXdlaWdodC1sb3NzLWRydWdzLWxpbmtlZC10by1yYXJlLWV5ZS1jb25kaXRpb24tc3R1ZHkuaHRtbNIBAA?oc=5" target="_blank">Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition</a>&nbsp;&nbsp;<font color="#6f6f6f">CNBC</font></li><li><a href="https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3LmJ1c2luZXNzaW5zaWRlci5jb20vc3R1ZHktb3plbXBpYy1saW5rZWQtdG8tcmFyZS1jYXNlcy1vZi1ibGluZG5lc3MtMjAyNC030gFaaHR0cHM6Ly93d3cuYnVzaW5lc3NpbnNpZGVyLmNvbS9zdHVkeS1vemVtcGljLWxpbmtlZC10by1yYXJlLWNhc2VzLW9mLWJsaW5kbmVzcy0yMDI0LTc_YW1w?oc=5" target="_blank">Study: Ozempic linked to rare cases of blindness</a>&nbsp;&nbsp;<font color="#6f6f6f">Business Insider</font></li><li><a href="https://news.google.com/rss/articles/CBMiiQFodHRwczovL3d3dy50aGVndWFyZGlhbi5jb20vc2NpZW5jZS9hcnRpY2xlLzIwMjQvanVsLzAzL3N0dWR5LXBvc3NpYmxlLWxpbmstd2VpZ2h0LWxvc3MtamFicy13ZWdvdnktb3plbXBpYy1hbmQtbmFpb24tY29uZGl0aW9uLWJsaW5kbmVzc9IBiQFodHRwczovL2FtcC50aGVndWFyZGlhbi5jb20vc2NpZW5jZS9hcnRpY2xlLzIwMjQvanVsLzAzL3N0dWR5LXBvc3NpYmxlLWxpbmstd2VpZ2h0LWxvc3MtamFicy13ZWdvdnktb3plbXBpYy1hbmQtbmFpb24tY29uZGl0aW9uLWJsaW5kbmVzcw?oc=5" target="_blank">Weight-loss jabs may be linked to condition that can cause blindness, study finds</a>&nbsp;&nbsp;<font color="#6f6f6f">The Guardian</font></li><li><a href="https://news.google.com/rss/articles/CBMiQGh0dHBzOi8vbmV3YXRsYXMuY29tL21lZGljYWwvc2VtYWdsdXRpZGUtcHJlc2NyaXB0aW9uLWJsaW5kbmVzcy_SAQA?oc=5" target="_blank">Ozempic associated with up to 7x increased risk of rare 'eye stroke'</a>&nbsp;&nbsp;<font color="#6f6f6f">New Atlas</font></li></ol>]]></description><link>https://news.google.com/rss/articles/CBMihwFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy93ZWdvdnktb3plbXBpYy1saW5rZWQtd2l0aC1zaWdodC10aHJlYXRlbmluZy1leWUtZGlzb3JkZXItc3R1ZHktMjAyNC0wNy0wMy_SAQA?oc=5</link><guid isPermaLink="true">https://news.google.com/rss/articles/CBMihwFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy93ZWdvdnktb3plbXBpYy1saW5rZWQtd2l0aC1zaWdodC10aHJlYXRlbmluZy1leWUtZGlzb3JkZXItc3R1ZHktMjAyNC0wNy0wMy_SAQA?oc=5</guid><pubDate>Wed, 03 Jul 2024 23:48:00 GMT</pubDate></item><item><title><![CDATA[2 Elite Growth Stocks to Buy and Hold for the Next Decade]]></title><link>https://finance.yahoo.com/news/2-elite-growth-stocks-buy-074500461.html</link><guid isPermaLink="true">https://finance.yahoo.com/news/2-elite-growth-stocks-buy-074500461.html</guid><pubDate>Thu, 04 Jul 2024 07:45:00 GMT</pubDate></item><item><title><![CDATA[Mark Cuban Asked ChatGPT Whether It Would Hire Trump Or Biden For A 'Job' Based Solely On The Debate Transcript — Here's Who It Chose]]></title><link>https://finance.yahoo.com/news/mark-cuban-asked-chatgpt-whether-155504071.html</link><guid isPermaLink="true">https://finance.yahoo.com/news/mark-cuban-asked-chatgpt-whether-155504071.html</guid><pubDate>Wed, 03 Jul 2024 15:55:04 GMT</pubDate></item><item><title><![CDATA[These 4 Vanguard ETFs Soared Over 20% in the First Half of 2024. Here's Which One Is Most Likely to Fly Even Higher.]]></title><link>https://finance.yahoo.com/news/4-vanguard-etfs-soared-over-094900355.html</link><guid isPermaLink="true">https://finance.yahoo.com/news/4-vanguard-etfs-soared-over-094900355.html</guid><pubDate>Wed, 03 Jul 2024 09:49:00 GMT</pubDate></item></channel></rss>